Boston Scientific : 2021 Performance Report

Introduction

Patient spotlight

Table of contents

A message from our Chairman and Chief Executive Officer

Our mission and values

Boston Scientific: 2021 at a glance

Our ESG strategy 2021 highlights

Awards and recognition

Transforming care

Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix

2

2021 Performance Report

Patient spotlight: Arnold Vargas Gonzalez

Not long after joining Boston Scientific, Arnold Vargas Gonzalez sensed it would be more than just a job. "The Boston Scientific quality culture inspired me right away," says the 39-year-old, who is based in Coyol, Costa Rica.

Arnold worked hard to progress from product builder to quality inspector, and with encouragement and support from his leaders and colleagues, he pursued a degree in industrial engineering to advance his career in quality.

After earning a promotion to quality engineer, Arnold suffered gallbladder complications, which led to a critical surgery. When doctors showed him the stent they were using, he knew he would make a full recovery. "I saw the Boston Scientific logo and it gave me such peace of mind. I believed in the device because we built it." Arnold was soon back on the quality front lines and to his studies.

Arnold and his wife Eimy, who also works in manufacturing at our Coyol site, are inspired to make life better for patients every day.

In 2021, amid global uncertainty, Arnold and his team stood strong - along with 41,000 Boston Scientific colleagues around the world. Across the company, our people innovated to improve patient outcomes, stay connected with customers and deliver solutions wherever they were needed.

The collective resolve of our global team accelerated our progress as a business and as a corporate citizen. We found new ways to support our communities, protect the environment we all share and make care more equitable.

Like Arnold, we believe - in the power of doing our part, always working for a better future and advancing science for life.

"I knew my future would be here, making our products - always with the patient in mind."

Arnold Vargas Gonzalez engineer,

Quality Assurance and Boston Scientific patient

Introduction

Patient spotlight

Table of contents

A message from our Chairman and Chief Executive Officer

Our mission and values

Boston Scientific: 2021 at a glance

Our ESG strategy 2021 highlights

Awards and recognition

Transforming care

Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix

3

2021 Performance Report

Table of contents

This report has been prepared in reference to the Global Reporting Initiative guidelines and the SASB standards for the Medical Equipment & Supplies industry. Unless otherwise indicated, data in this 2021 Performance Report and appendix are as of December 31, 2021, or for the year ended December 31, 2021, as applicable. Please refer to the appendix for detailed metrics and key definitions used within this report. Reporting on other matters specific to financial performance of the company and its subsidiaries can be found in our 2021 Annual Report.

Patient spotlight: Arnold Vargas Gonzalez 2

A message from our Chairman

and Chief Executive Officer 4

Our mission and values 6

Boston Scientific: 2021 at a glance 7

Our ESG strategy: Advancing science for life 8

2021 highlights 11

Awards and recognition 12

Transforming care 13

Innovating to meet more patient needs 14

Ensuring quality, health and safety 17

Improving access and outcomes

through digital solutions 19

Investing in our people 20

Our diverse, equitable and inclusive workplace 21

Attracting, developing and retaining talent 25

Employee well-being, rewards and safety 28

Accelerating possibilities 31

Improving health equity and access 32

Confronting inequities 35

Supporting our communities 36

Protecting the environment 39

Reducing our environmental impact 40

Managing climate risk 45

Advancing product stewardship 46

Creating value responsibly 48

Good governance reflects our values 49

Compliance, ethics and integrity 50

Protecting human rights across our

company and supply chain 51

Keeping our supply chain resilient and reliable 52

Risk management and global security 53

Keeping our products and patient data secure 54

Appendix 55

Stakeholder engagement 56

Metrics summary 57

Global Reporting Initiative (GRI) index 68

Sustainability Accounting Standards Board

(SASB) index 75

United Nations Sustainable Development

Goals (SDGs) 77

Introduction

Patient spotlight

Table of contents

A message from our Chairman and Chief Executive Officer

Our mission and values

Boston Scientific: 2021 at a glance

Our ESG strategy 2021 highlights

Awards and recognition

Transforming care

Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix

4

2021 Performance Report

At Boston Scientific, we have always been dedicated to advancing science for life. Now more than ever - at a time when we face continued challenges and uncertainty as a global community - we are hopeful and united by our mission and values to create a healthier, brighter future for one another and for our planet.

We remain confident in our progress and committed to transforming care, investing in our people, accelerating possibilities, protecting the environment and creating value responsibly. Our 2021 performance report is one example of our efforts to be transparent and accountable to the public and our many stakeholders. We are committed to understanding and managing environmental, social and governance (ESG) opportunities and risks in our business practices.

Overall, performance across Boston Scientific businesses remains strong and our future is promising. We've accomplished a great deal as we learned to manage through the pandemic. In 2021, we invested more than $1 billion in research and development and launched 90 new products to advance patient care. We strengthened our digital capabilities to enhance patient engagement to facilitate remote education and training for health care providers. Our teams conducted 145 global clinical trials and received approximately 1,250 market approvals that expand access to our technologies. Above all, we improved the lives of more than 30 million patients.

Introduction

Patient spotlight

Table of contents

A message from our Chairman and Chief Executive Officer

Our mission and values

Boston Scientific: 2021 at a glance

Our ESG strategy 2021 highlights

Awards and recognition

Transforming care

Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix

5

2021 Performance Report

Addressing inequities in workplaces, communities and health care systems

The inequities in our workplaces, communities and health care systems have been starkly revealed over the last few years - by the pandemic, polarizing political environments, racial and social injustice and economic uncertainty. We have committed to support diversity, address health inequities and combat systemic racism and injustice both within Boston Scientific and our communities. In 2021, we made progress toward our goals by taking the following actions:

• • Deepened our diversity programs aimed at eliminating bias, racism and other forms of discrimination in our workplace as part of our 3Up by 2023 initiative, which is aimed at increasing representation of women and multicultural talent at the management level.

• • Introduced a human capital scorecard as part of our 2021 annual bonus program to hold ourselves accountable for building a more diverse and inclusive workplace and achieving our environmental goals.

• • Expanded relationships with certified companies that share our dedication to improving customer and patient care, which included investing more than $865 million in small and diverse suppliers to help us meet our business objectives through external collaborations.

• • Extended our advocacy across 28 national and local organizations as part of the second year of a $3.5 million multiyear strategy to combat inequity, systemic racism and injustice in the U.S.

• • Increased diversity in medical research and partnered with community health care providers to expand awareness of health disparities and address them through our Close the Gap health equity initiative.

• • Contributed more than $75 million in corporate donations to fund medical research, fellowships, education and charitable organizations globally.

• 1 Inclusive of all manufacturing and key distribution sites only.

• 2 Reflects adjustments to previously reported figure of 72% renewable electricity in our 2022 Annual Proxy Statement, based on subsequent internal audit.

Taking action for a healthier planet

By protecting the planet's health, we protect human health. That's why sustainable and inclusive business practices are central to our work to transform lives.

We are on track to achieve carbon neutrality by 2030 in all manufacturing and key distribution sites. In 2021, we committed to setting new science-based targets and reaching net-zero carbon emissions across our entire value chain by 2050.

So far, we've cut our energy usage by investing in and increasing energy efficiency at all of our sites. This includes new construction that meets the highest climate standards. Nearly half of Boston Scientific real estate - more than 4 million global square feet - currently meets International Organization for Standardization (ISO) and Leadership in Energy and Environmental Design (LEED) energy and environmental standards. We are also converting to renewable energy. In 2021, 73% of our electricity came from renewable sources (exceeding our interim goal of 50% by 2021) and we aim to source or generate 100% of our electricity from renewable sources by 2024.1,2 We are also pursuing efforts to better manage or reduce waste, conserve water and increase medical device recycling to minimize environmental impact of our products and packaging. To better protect our business and customers from climate-related disruption, our climate risk approach entails oversight, risk management and mitigation efforts throughout our business.

Creating a healthier, more equitable future

We have much work to do but we are making meaningful progress. The spirit and commitment of our global team has enabled us to succeed during uncertain times. We have a robust portfolio and pipeline, ambitious research and development, the highest quality standards and a deeply talented global team. Working together, we can continue to transform lives around the world through innovative medical solutions.

Chairman and Chief Executive Officer, Boston Scientific

Mike Mahoney